维普期刊资源整合服务平台（V6.5）

1437篇 您的检索式：作者名="LIP GY"

选中清除导出查看参考文献查看引证文献引用追踪共72页首页上一页第1页下一页末页 /72 跳转

	题名	作者	年代	出处	被引量
1	Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers 显示文摘	Blann AD Lip GY Beevers DG	1997	Thromb Haemost1997，77，6：	1
2	Assessment of mcan plalelet volume in coronaryarlery disease - What does it mean? 显示文摘	Boos CJ Lip GY	2007	Thrombosis Research2007，120，1：	1
3	Is hypertension an inflammatory process显示文摘	Boos CJ Lip GY	2006	Curr Pharm Des2006，12，：	1
4	The prothromb oticstate in hypertension and the effects of antihypertensive treatment显示文摘	Nadar S Lip GY	2003	Curr Pharm Des2003，9，21：	1
5	Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report显示文摘	Lip GY Blann AD Zarifis J	1995	J Hypertens1995，13，：	1
6	Platelet activation and cardiovascular outcomes in acute coronary syndromes 显示文摘	Boos CJ Lip GY	2006	J Thromb Haemost2006，4，12：	1
7	Mechanisms of thrombogenesis in atrial fibrillation:Virchow's triad revisited显示文摘	Watson T Shantsila E Lip GY	2009	Lancet2009，373，9658：	1
8	Management of atrial fibrillation 显示文摘	Lip GY Tse HF	2007	Lancet2007，370，9587：	1
9	Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fi- brillation of the European Society of Cardiology (ESC) 显示文摘	Camm AJ Kirehhof P Lip GY	2010	Europace2010，12，：	1
10	Stroke prevention with aspirin warfarin and ximelagatran in patients with non-valvular atrial fibrilla-tion:A system review and meta-analysis显示文摘	Lip GY Edwards SJ		0，，：	1
11	Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atriai Fibrillation of the European Society of Cardiology (ESC)显示文摘	Camm AJ Kirchhof P Lip GY	2010	Eur Heart J2010，31，19：	1
12	Stroke and major bleeding risk in elderly patients aged S 75 years with atrial fibrillation: the Loire Valley at- rial fibrillation project 显示文摘	Lip GY Clementy N Pericart L	2015	Stroke2015，46，1：	1
13	Stroke and bleeding risk assessment in atrial fibrillation:when,how,and why显示文摘	Lip GY	2013	Eur Heart J2013，34，14：	1
14	Does heart failure confer a hypercoagulable state Virchow's triad revesited显示文摘	Lip GY Gibbs GR	1999	J Am Coll Cardiol1999，33，：	1
15	Implications of the LIFE trial 显示文摘	Nadar S Lim HS Lip GY	2003	Expert Opin Investig Drugs2003，12，5：	1
16	Home - based cardiac re- habilitation compared with centre - based rehabilitation and usual care : a systematic review and meta - analysis 显示文摘	Jolly K Taylor RS Lip GY	2006	Int J Cardiol2006，111，：	1
17	Guidelines for the management of atrial fibrillation:the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology(ESC)显示文摘	1 Camm AJ Kirchhof P Lip GY	2010	Eur Heart J2010，，31：	1
18	Stroke prevention with aspirin, warfarin and ximelagatran in patients with non- valvular atrial fibrillation:a systematic review and meta-analysis显示文摘	Lip GY Edwards SJ	2006	Thromb Res2006，118，：	1
19	Hypothesis: is soluble P-selectin a new marker of platelet activation? 显示文摘	Blann AD Lip GY	1997	Atherosclerosis1997，128，2：	1
20	Implications of the LIFE trial显示文摘	Nadar S Lim HS Lip GY	2003	Expert Opin Investig Drugs2003，12，5：	1

返回顶部每页显示：

共72页首页上一页第1页下一页末页 /72 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示